Ọgwụ hypoglycemic

nwamba # Aha ngwaahịa Nkọwa
CPD0004 Ertugliflozin Ertugliflozin, nke a makwaara dị ka PF-04971729, bụ onye na-egbochi ike na nhọrọ nke onye na-ahụ maka glucose na-adabere na sodium na onye na-akwado ụlọ ọgwụ maka ọgwụgwọ ụdị ọrịa shuga mellitus 2.
CPDA0048 Omarigliptin Omarigliptin, nke a makwaara dị ka MK-3102, bụ onye na-egbochi DPP-4 na-eme ogologo oge maka ọgwụgwọ ụdị ọrịa shuga 2 kwa izu.
CPDA1089 Retagliptin Retagliptin, nke a makwaara dị ka SP-2086, bụ ihe mgbochi DPP-4 nwere ike iji maka ọgwụgwọ ụdị ọrịa shuga 2.
CPDA0088 Trelagliptin Trelagliptin, nke a makwaara dị ka SYR-472, bụ ihe mgbochi dipeptidyl peptidase-4 (DPP-4) na-eme ogologo oge nke Takeda na-emepụta maka ọgwụgwọ ụdị ọrịa shuga 2 (T2D).
CPDA2039 Linagliptin Linagliptin, makwaara dị ka BI-1356, bụ ihe mgbochi DPP-4 nke Boehringer Ingelheim mepụtara maka ọgwụgwọ ụdị ọrịa shuga II.
CPDA0100 Sitagliptin Sitagliptin (INN; nke amataburu dị ka MK-0431 ma ree ya n'okpuru aha azụmaahịa Januvia) bụ ọgwụ antihyperglycemic ọnụ (ọgwụ mgbochi ọrịa shuga) nke klaasị inhibitor dipeptidyl peptidase-4 (DPP-4).
CPD0854 LX-4211 LX-4211 bụ ihe mgbochi SGLT2/1 nwere ike; Ọgwụ antidiabetic.
CPDA1553 LX-2761 LX2761 bụ ihe mgbochi SGLT1 na-eme mpaghara nke nwere ike dị ukwuu na vitro ma na-egbu oge nnabata glucose eriri afọ na vivo iji melite njikwa glycemic.
nke

Kpọtụrụ anyị

Ajuju

Akụkọ kacha ọhụrụ

Mkparịta ụka WhatsApp n'ịntanetị!
Close